White labeling is often pitched as the fastest, lowest-cost way to bring a cannabis brand to market. In many cases, it actually is. But speed and accessibility can mask serious risks — especially when the contracts and relationships underneath haven't been properly vetted.
In a recent conversation between Tyler Bartosh of Spire Insurance Solutions and cannabis attorney Ryan Kocot, one theme kept resurfacing: white labeling decisions live or die on the strength of the business relationship behind them.
The Illusion of Control
In a typical white label agreement, the brand owns the intellectual property while a producer handles the plant-touching operations. On paper, that arrangement looks clean. In practice, the brand often has far less control than its owners realize.
What you may not actually control:
- How your products are manufactured
- Quality assurance standards on the production floor
- Packaging timelines
- The execution of label artwork and copy
In some cases, Kocot notes, brand owners haven't even met their producer in person before signing — a scenario he calls deeply concerning for an industry where reputational and regulatory risk move fast.
Why Contracts Alone Aren't Enough
White labeling is fundamentally a contractual relationship. Your protections live and die by what's written into the agreement, and by what's missing from it.
Common problem areas Kocot flags:
- Vague payment definitions — net versus gross, deductions, holdback windows
- Unclear ownership language around IP, formulas, and packaging artwork
- Poorly defined exclusivity terms that let producers serve competing brands
- Missing approval workflows for packaging and labeling changes
When these details aren't explicit upfront, downstream disputes become near-inevitable and expensive.
The Takeaway
White labeling can be a powerful growth strategy. It works best when paired with three things: strong due diligence on the production partner, clear contractual structure, and aligned incentives between the brand and the producer.
Speed gets product on shelves. Structure keeps brands alive.
Where Insurance Fits In
The flip side of contractual ambiguity is insurance coverage uncertainty. When a products liability claim hits, the carrier traces the chain of custody — who manufactured, who packaged, who labeled, who sold — and decides where the loss attaches. If the underlying contract is unclear about those roles, the coverage picture gets unclear too.
If white labeling is part of your strategy, a Spire agent can walk you through how your products liability, business interruption, and contractual liability coverages interact with your producer agreement. Coverage is subject to underwriting.
Ryan Kocot is a cannabis attorney. This article summarizes themes from a conversation between Kocot and Tyler Bartosh of Spire Insurance Solutions; it is general educational information and does not constitute legal advice. For legal questions about your specific contract or operation, consult a licensed attorney.
